Cytokinetics Inc Working Capital to Net Assets Ratio
Cytokinetics Inc working capital to net assets ratio. Cytokinetics Inc (CYTK) has a Working Capital to Net Assets ratio of -592.0% as of June 2026. Working capital of $1.03 Billion (current assets of $1.21 Billion minus current liabilities of $181.43 Million) is measured against net assets of $-173.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cytokinetics Inc (2002–2025)
Working capital to net assets ratio of Cytokinetics Inc from 2002 to 2025. This chart shows how Cytokinetics Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2026, the ratio stands at -592.0%, reflecting working capital of $1.03 Billion against net assets of $-173.49 Million USD. Explore CYTK strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cytokinetics Inc Working Capital to Net Assets Ratio by Year (2002–2025)
Cytokinetics Inc working capital to net assets ratio by year from 2002 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cytokinetics Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CYTK total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -108.3% | $714.52 Million | $-659.62 Million | $916.98 Million | $202.45 Million | ▲ +577.4 pp |
| 2024 | -685.7% | $928.27 Million | $-135.37 Million | $1.11 Billion | $179.67 Million | ▼ -549.7 pp |
| 2023 | -136.0% | $525.37 Million | $-386.32 Million | $628.05 Million | $102.68 Million | ▲ +522.6 pp |
| 2022 | -658.5% | $710.57 Million | $-107.90 Million | $795.19 Million | $84.62 Million | ▼ -848.7 pp |
| 2021 | 190.2% | $463.81 Million | $243.86 Million | $535.67 Million | $71.86 Million | ▼ -200.5 pp |
| 2020 | 390.7% | $443.02 Million | $113.38 Million | $474.22 Million | $31.20 Million | ▲ +2290.1 pp |
| 2019 | -1899.3% | $207.73 Million | $-10.94 Million | $233.75 Million | $26.02 Million | ▼ -2614.5 pp |
| 2018 | 715.2% | $185.48 Million | $25.93 Million | $207.67 Million | $22.19 Million | ▲ +495.0 pp |
| 2017 | 220.2% | $241.85 Million | $109.84 Million | $274.30 Million | $32.44 Million | ▲ +87.3 pp |
| 2016 | 132.9% | $125.38 Million | $94.36 Million | $158.63 Million | $33.26 Million | ▲ +14.1 pp |
| 2015 | 118.8% | $81.46 Million | $68.59 Million | $113.11 Million | $31.65 Million | ▲ +2.2 pp |
| 2014 | 116.5% | $107.28 Million | $92.06 Million | $131.13 Million | $23.86 Million | ▲ +19.8 pp |
| 2013 | 96.7% | $52.63 Million | $54.44 Million | $79.34 Million | $26.70 Million | ▼ -2.3 pp |
| 2012 | 98.9% | $70.68 Million | $71.44 Million | $76.43 Million | $5.75 Million | ▲ +2.3 pp |
| 2011 | 96.6% | $46.55 Million | $48.18 Million | $51.14 Million | $4.59 Million | ▲ +2.8 pp |
| 2010 | 93.8% | $66.17 Million | $70.52 Million | $73.50 Million | $7.32 Million | ▼ -1.5 pp |
| 2009 | 95.4% | $96.74 Million | $101.43 Million | $116.92 Million | $20.18 Million | ▲ +23.0 pp |
| 2008 | 72.4% | $36.03 Million | $49.77 Million | $58.91 Million | $22.88 Million | ▼ -23.2 pp |
| 2007 | 95.6% | $95.57 Million | $99.92 Million | $122.02 Million | $26.45 Million | ▼ -24.0 pp |
| 2006 | 119.7% | $127.23 Million | $106.31 Million | $153.62 Million | $26.39 Million | ▲ +27.8 pp |
| 2005 | 91.9% | $67.60 Million | $73.56 Million | $78.86 Million | $11.26 Million | ▲ +0.8 pp |
| 2004 | 91.1% | $98.03 Million | $107.56 Million | $109.07 Million | $11.04 Million | ▲ +121.2 pp |
| 2003 | -30.0% | $27.62 Million | $-92.03 Million | $37.08 Million | $9.46 Million | ▲ +0.6 pp |
| 2002 | -30.7% | $18.57 Million | $-60.59 Million | $27.95 Million | $9.38 Million | — |